Next Article in Journal
Isolation, Virulence, and Antimicrobial Resistance of Methicillin-Resistant Staphylococcus aureus (MRSA) and Methicillin Sensitive Staphylococcus aureus (MSSA) Strains from Oklahoma Retail Poultry Meats
Previous Article in Journal
Waterpipe Smoking and Regulation in the United States: A Comprehensive Review of the Literature
Article Menu

Export Article

Open AccessArticle
Int. J. Environ. Res. Public Health 2015, 12(6), 6136-6147; doi:10.3390/ijerph120606136

Does Treatment Impact Health Outcomes for Patients After Acute Coronary Syndrome?

1
Department of Preventive Medicine, Lithuanian University of Health Sciences, 57-302 Šiaurės ave, Kaunas LT-49264, Lithuania
2
Institute of Cardiology, Lithuanian University of Health Sciences, 17 Sukilėlių ave, Kaunas LT-50009, Lithuania
*
Author to whom correspondence should be addressed.
Academic Editor: Paul B. Tchounwou
Received: 21 April 2015 / Revised: 17 May 2015 / Accepted: 22 May 2015 / Published: 29 May 2015
View Full-Text   |   Download PDF [698 KB, uploaded 29 May 2015]

Abstract

Background: Mortality rates for acute coronary syndrome (ACS) patients are still very high all over the world. Our study aimed to investigate the impact of ACS treatment on cardiovascular (CV) mortality eight years following ACS. Methods: A retrospective cohort study with a total of 613 patients was used. The data was collected from databases and medical records. An evidence-based treatment (EBT) algorithm was used based on the ESC guidelines. Logistic regression analysis and standardized odds ratios with 95% confidence interval (CI) were used for the risk assessment, with a p level < 0.05 considered as significant. Results: The median follow-up time in this study was 7.6 years. During follow-up 48.9% of the patients (n = 300) died from CV and 207 (69%) for a relevant reason. For monotherapy ACE inhibitors and β-blockers, and for fixed dose combined drugs ACE inhibitors and diuretics, were most frequently used. EBT was provided to 37.8% of patients. The EBT use (HR 0.541, CI 0.394–0.742, p < 0.001) during follow-up period was important for reducing CV mortality in ACS patients. Conclusions: The combined use of EBT significantly improved outcomes. The recurrent myocardial infarction and percutaneous coronary intervention patients were more frequent in EBT and it was beneficial for reducing CV mortality. View Full-Text
Keywords: cardiovascular mortality; evidence-based treatment cardiovascular mortality; evidence-based treatment
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Umbrasienė, J.; Vanagas, G.; Venclovienė, J. Does Treatment Impact Health Outcomes for Patients After Acute Coronary Syndrome? Int. J. Environ. Res. Public Health 2015, 12, 6136-6147.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Environ. Res. Public Health EISSN 1660-4601 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top